scispace - formally typeset
Open AccessJournal ArticleDOI

Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation.

Reads0
Chats0
TLDR
It is shown that MetAP-2 can be tethered to SCFβ-TRCP, ubiquitinated, and degraded in a Protac-1-dependent manner, which may be useful for conditional inactivation of proteins, and for targeting disease-causing proteins for destruction.
Abstract
The intracellular levels of many proteins are regulated by ubiquitin-dependent proteolysis. One of the best-characterized enzymes that catalyzes the attachment of ubiquitin to proteins is a ubiquitin ligase complex, Skp1-Cullin-F box complex containing Hrt1 (SCF). We sought to artificially target a protein to the SCF complex for ubiquitination and degradation. To this end, we tested methionine aminopeptidase-2 (MetAP-2), which covalently binds the angiogenesis inhibitor ovalicin. A chimeric compound, protein-targeting chimeric molecule 1 (Protac-1), was synthesized to recruit MetAP-2 to SCF. One domain of Protac-1 contains the IκBα phosphopeptide that is recognized by the F-box protein β-TRCP, whereas the other domain is composed of ovalicin. We show that MetAP-2 can be tethered to SCFβ-TRCP, ubiquitinated, and degraded in a Protac-1-dependent manner. In the future, this approach may be useful for conditional inactivation of proteins, and for targeting disease-causing proteins for destruction.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Small molecule therapeutics targeting F-box proteins in cancer

TL;DR: How F-box proteins function in cancer and potential small molecule inhibitors for cancer therapy are reviewed and summarized.
Journal ArticleDOI

Modeling the CRL4A ligase complex to predict target protein ubiquitination induced by cereblon-recruiting PROTACs

TL;DR: In this paper , a structure-based computational approach was proposed to predict target protein ubiquitination induced by cereblon-based PROTACs by leveraging available structural information of the CRL4A ligase complex (CRBN/DDB1/CUL4A/Rbx1/NEDD8/E2/Ub).
Journal ArticleDOI

Development of a PDEδ‐Targeting PROTACs that Impair Lipid Metabolism

TL;DR: In this paper, the prenyl-protein chaperone PDEδ modulates the localization of lipidated proteins in the cell, but current knowledge about its biological function is limited.
Journal ArticleDOI

VHL-based PROTACs as potential therapeutic agents: Recent progress and perspectives

TL;DR: Proteolysis targeting chimeras (PROTACs) are a novel drug discovery paradigm that has been widely used as biological tools and medicinal molecules with the potential of clinical application value.
Journal ArticleDOI

Aberrant Activation of NF-κB Signalling in Aggressive Lymphoid Malignancies.

TL;DR: The knowledge gained from these studies may be exploited for the development of therapeutic strategies to inhibit aberrant NF-κB activity at the level of the transcription-factor subunits and their target genes, as global inhibition of the pathway is toxic.
References
More filters
Journal ArticleDOI

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

TL;DR: Recent progress has been made in understanding the details of the signaling pathways that regulate NF-kappaB activity, particularly those responding to the proinflammatory cytokines tumor necrosis factor-alpha and interleukin-1.
Journal ArticleDOI

IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation

TL;DR: In this article, a large multiprotein complex, the IkappaB kinase (IKK) signalsome, was purified from HeLa cells and found to contain a cytokine-inducible IKK kinase activity that phosphorylates IappaB-alpha and IKK-beta.
Journal ArticleDOI

SCF and Cullin/RING H2-Based Ubiquitin Ligases

TL;DR: This review is focused on a conserved ubiquitin ligase complex known as SCF that plays a key role in marking a variety of regulatory proteins for destruction by the 26S proteasome.
Journal ArticleDOI

Transduction of full-length TAT fusion proteins into mammalian cells:TAT-p27Kip1 induces cell migration

TL;DR: Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27 Kip1 induces cell migration and promotes cell migration in mice.
Journal ArticleDOI

Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity

TL;DR: In this article, the authors used biotinylated-epoxomicin as a molecular probe and showed that it covalently binds to the LMP7, X, MECL1, and Z catalytic subunits of the proteasome.
Related Papers (5)